Zobrazeno 1 - 2
of 2
pro vyhledávání: '"David Jeffrey Huss"'
Autor:
Polina Sysa-Shah, Jon Jones, Steven P. Rowe, Yong Du, Andrew Park, Mary Brummet, Tamara M. Chinn, David Jeffrey Huss, Hye Hyun Ahn, Il Minn, Martin G. Pomper, Hyam I. Levitsky
Publikováno v:
Radiol Imaging Cancer
Chimeric antigen receptor (CAR) T cell therapy for hematologic malignancies is fraught with several unknowns, including number of functional T cells that engage target tumor, durability and subsequent expansion and contraction of that engagement, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e6cbf59ddbb01820468dfdbf50bbb83
https://pubmed.ncbi.nlm.nih.gov/33778677
https://pubmed.ncbi.nlm.nih.gov/33778677
Autor:
Ruth Salmon, Eric M. Chadwick, Bailey Donahue, Melissa Chin, G. Grant Welstead, Clay Patton, Blythe D. Sather, Stephen Michael Burleigh, Dean Y. Toy, Brian J. Belmont, David Jeffrey Huss, Alexandra Croft, Stephen J. Goldfless, Cameron S. Brandt
Publikováno v:
Cancer Immunology Research. 7:A027-A027
Background: Adoptive T-cell therapy with engineered T-cell receptors (eTCR) has demonstrated promising, yet modest clinical benefit to date. Key obstacles for this technology are 1) competition with the endogenous TCR for CD3 components that are requ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3c119b6b86fcccb5af7ff0ffe56dc0b
https://doi.org/10.1158/2326-6074.cricimteatiaacr18-a027
https://doi.org/10.1158/2326-6074.cricimteatiaacr18-a027